EUVIMEDEUVIMED entdecken
Open Access

CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia

Myrto Eleni Flokas iD, Li Yang, Kimberly R Middleton, Sarah Kollender, Megan Parker, Charles Sukin, Rebecca Wood Persky, Deborah P Merke iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Myrto Eleni Flokas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, Children's National Hospital, Washington, DC 20010, USA. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Quality of Life, Patient Reported Outcome Measures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Measuring health-related quality of life (HRQoL) is a crucial aspect of evaluating health care outcomes. Patients with congenital adrenal hyperplasia (CAH) often self-report deficiencies in HRQoL.

Objective

The aim of our study was to develop a disease-specific patient-reported outcome (PRO) instrument to evaluate the HRQoL of patients > 16 years old with classic CAH.

Methods

Following the FDA guidelines for developing PRO instruments, we developed a conceptual framework for the instrument. A preliminary instrument was created after interviewing a representative sample of 12 patients (aged 16 to 68 years) with CAH and 3 parents and obtaining expert feedback from 4 endocrinologists. The instrument was edited after cognitive interviews with 6 patients. Internal consistency of the instrument was evaluated using Cronbach's alpha. Validity was assessed by comparing the scores of our instrument with scores from widely used validated instruments for HRQoL and PRO not specific to CAH.

Results

Sixty-nine patients 16 to 75 years old participated in validating our preliminary instrument. The final questionnaire consists of 44 questions within 7 domains: General Health, Adrenal Insufficiency, Glucocorticoid Excess, Physical Functioning, Mental Health and Cognition, Social Functioning, and Sexual Functioning, with acceptable internal consistency (Chronbach's alpha ≥ .6) and validity (r = −0.350 to 0.866).

Conclusion

CAHQL is the first validated PRO instrument to capture disease-specific HRQoL outcomes in CAH. In addition to its anticipated use in the clinical setting, the instrument could be used to assess the efficacy of novel treatments in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalQuality of LifePatient Reported Outcome MeasuresHumansAdultMaleFemaleAdolescentMiddle AgedAgedYoung AdultSurveys and QuestionnairesReproducibility of ResultsPsychometrics

Stichwörter der Autor:innen

CAHPROcongenital adrenal hyperplasiahealth-related quality of lifepatient-reported outcomes

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetes, Children's National Hospital, Washington, DC 20010, USA.
  • The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892-1932, USA.
  • Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892-1932, USA.

ORCID-Profile: Myrto Eleni Flokas, Deborah P Merke

Förderung

  • National Institutes of Health

Zitieren

APA

Flokas, M. E., Yang, L., Middleton, K. R., Kollender, S., Parker, M., Sukin, C., Persky, R. W., & Merke, D. P. (2025). CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae309

Vancouver

Flokas ME, Yang L, Middleton KR, Kollender S, Parker M, Sukin C, et al. CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae309

BibTeX
@article{Flokas2025,
  author = {Flokas, Myrto Eleni and Yang, Li and Middleton, Kimberly R and Kollender, Sarah and Parker, Megan and Sukin, Charles and Persky, Rebecca Wood and Merke, Deborah P},
  title = {CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae309}
}
Kostenlos starten →